The Patient Perspective – RSV Vaccine

The Patient Perspective

RSV Vaccine

Respiratory Syncytial Virus (RSV) is an easily transmittable virus that effects the lungs and airways, with symptoms similar to the flu or COVID-19. RSV infection represents a potential medical emergency for the young and the old. Right now, there are no approved vaccine options. Research studies can lead to impressive medical milestones like developing the first RSV vaccine. Our participant volunteers play a vital role in making that happen.

Nothing excites us more than talking with one of our patients. We asked retired Obstetrician Dr. Michael Hoffman, who participated in an RSV vaccine study, to answer a few questions for us. This is what he had to say.

Why did you chose to participate in an RSV vaccine research study?

RSV is important to me because, as an Obstetrician, I’ve delivered many babies. About 20 years ago, when I asked mothers how their baby was, some would say it was in ICU due to a new virus called RSV. That was the first I heard of it. Clinical research is important because it's the only way to prove that what you think is happening is actually happening and working. Vaccines make a huge difference in who gets the disease. I thought if we could prevent people from getting RSV and dying from it; I’m all for that! When Accellacare called me for a study on RSV and said they had a vaccine to prevent it, I said, "Sign me up!"

Why did you participate with Accellacare? 

When I met the staff, they were so kind and nice to me. The organization was so well put together; I had to sign up.

What was your participation experience like? 

I like Accellacare because the follow up is very good. The emails and text I got were very exact and easy to follow.

Dr. Hoffman has been a part of developing an RSV vaccine that aims to provide protection from RSV virus that puts many infants and seniors at risk for severe infection. If you are interested in joining him in the process of developing an RSV vaccine, consider joining our study. You can sign up to learn more today here.


When you register your interest with Accellacare, our clinical research specialists will review your information at no cost and connect you with studies you may be eligible for. When we find a match, Accellacare may contact you for further pre-screening or we may share your information with a local site office for them to contact you directly. Your data will be processed as outlined in the Accellacare privacy policy


Data Protection

As the data controller for the Improvingtreatments.co.uk, Accellacare is committed to protecting the information that you provide. Where you give us your consent, we may use your information to: (a) identify appropriate clinical trials for you and to let you know about them; and/or (b) send you invitations to participate in future study opportunities. You can withdraw your consent at any time, but we may continue some limited processing where we have other legal grounds for doing so.

Please enter the security code: